glp-1/gip/glucagon triple agonist name TrimRX GLP-1/GIP/Glucagon Triple Receptor Agonist -

found that tirzepatide led to significant dose-dependent reductions in HbA1c levels when compared to a placebo, once-weekly GLP-1RAs, and basal insulin regimens

Jensen MH, Kjolby M, Hejlesen O, et al

46 The side effect profile of the antipsychotic agent is an important factor in the decision regarding which antipsychotic medication is commenced first

[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Wilding J.P.H., Batterham R.L., Calanna S., et al

Semaglutide activates (an agonist) the GLP-1 receptor, while tirzepatide is in a new class of dual agonists: it activates (mimics) both the GLP-1 receptor and GIP receptors (Gastric inhibit polypeptide is also known as glucose-dependent insulinotropic polypeptide.) The potency of activation for tirzepatide is 5-fold more for GIPR than GLP1